GSK agreed to confidentially settle another lawsuit in California that had alleged its discontinued heartburn drug Zantac caused cancer, the latest in a series of settlements made by the British drugmaker to end costly litigation. The case, which was set to begin trial on April 2, will be dismissed. GSK does not admit to any liability in this settlement with Boyd/Steenvoord, it said on Thursday.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Google Ads down as service disruption reported

Google Ad users have been facing issues accessing the platform since 1pm…

Rupee shoots past 209 against US dollar

Karachi: On Monday, the Pakistani rupee plunged further and crossed the 210…

Oil industry foresees petrol and diesel shortage: OGRA

Karachi: The oil industry communicated to the government about an expected petrol…

Fitch downgrades Pakistan’s rating

Fitch Ratings downgraded Pakistan’s Long-Term Foreign-Currency Issuer Default Rating (IDR) to “CCC-”…